The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Obesity Treating Neuromodulation System-Global Market Insights and Sales Trends 2024
Synopsis
Neuromodulation has shown some benefit in treatment of obesity and it is less invasive than the gastric banding and gastric bypass, which are surgical treatment option for obesity. Obesity treating neuromodulation system works by manipulation the appetite signal between gut and the brain.
The global Obesity Treating Neuromodulation System market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Obesity Treating Neuromodulation System in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Obesity Treating Neuromodulation System market. Vagus Nerve Stimulator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Splanchnic Nerve Stimulator segment is estimated at % CAGR for the next seven-year period.
North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Obesity Treating Neuromodulation System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Obesity Treating Neuromodulation System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Obesity Treating Neuromodulation System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Obesity Treating Neuromodulation System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Obesity Treating Neuromodulation System covered in this report include Medtronic, Cyberonics, Abbott, BioControl Medical, Leptos Medical, ReShape Lifesciences, Nevro and Nuvectra, etc.
The global Obesity Treating Neuromodulation System market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Cyberonics
Abbott
BioControl Medical
Leptos Medical
ReShape Lifesciences
Nevro
Nuvectra
Global Obesity Treating Neuromodulation System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Obesity Treating Neuromodulation System market, Segment by Type:
Vagus Nerve Stimulator
Splanchnic Nerve Stimulator
Deep Brain Stimulator
Spinal Cord Stimulator
Autonomous Nerve Stimulator
Others
Global Obesity Treating Neuromodulation System market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Obesity Treating Neuromodulation System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Obesity Treating Neuromodulation System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Neuromodulation has shown some benefit in treatment of obesity and it is less invasive than the gastric banding and gastric bypass, which are surgical treatment option for obesity. Obesity treating neuromodulation system works by manipulation the appetite signal between gut and the brain.
The global Obesity Treating Neuromodulation System market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Obesity Treating Neuromodulation System in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Obesity Treating Neuromodulation System market. Vagus Nerve Stimulator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Splanchnic Nerve Stimulator segment is estimated at % CAGR for the next seven-year period.
North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Obesity Treating Neuromodulation System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Obesity Treating Neuromodulation System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Obesity Treating Neuromodulation System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Obesity Treating Neuromodulation System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Obesity Treating Neuromodulation System covered in this report include Medtronic, Cyberonics, Abbott, BioControl Medical, Leptos Medical, ReShape Lifesciences, Nevro and Nuvectra, etc.
The global Obesity Treating Neuromodulation System market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Cyberonics
Abbott
BioControl Medical
Leptos Medical
ReShape Lifesciences
Nevro
Nuvectra
Global Obesity Treating Neuromodulation System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Obesity Treating Neuromodulation System market, Segment by Type:
Vagus Nerve Stimulator
Splanchnic Nerve Stimulator
Deep Brain Stimulator
Spinal Cord Stimulator
Autonomous Nerve Stimulator
Others
Global Obesity Treating Neuromodulation System market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Obesity Treating Neuromodulation System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Obesity Treating Neuromodulation System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Obesity Treating Neuromodulation System Market Overview
1.1 Obesity Treating Neuromodulation System Product Overview
1.2 Obesity Treating Neuromodulation System Market Segment by Type
1.2.1 Vagus Nerve Stimulator
1.2.2 Splanchnic Nerve Stimulator
1.2.3 Deep Brain Stimulator
1.2.4 Spinal Cord Stimulator
1.2.5 Autonomous Nerve Stimulator
1.2.6 Others
1.3 Global Obesity Treating Neuromodulation System Market Size by Type
1.3.1 Global Obesity Treating Neuromodulation System Market Size Overview by Type (2018-2029)
1.3.2 Global Obesity Treating Neuromodulation System Historic Market Size Review by Type (2018-2023)
1.3.3 Global Obesity Treating Neuromodulation System Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Obesity Treating Neuromodulation System Sales Breakdown by Type (2018-2023)
1.4.2 Europe Obesity Treating Neuromodulation System Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Obesity Treating Neuromodulation System Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Obesity Treating Neuromodulation System Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Obesity Treating Neuromodulation System Sales Breakdown by Type (2018-2023)
2 Global Obesity Treating Neuromodulation System Market Competition by Company
2.1 Global Top Players by Obesity Treating Neuromodulation System Sales (2018-2023)
2.2 Global Top Players by Obesity Treating Neuromodulation System Revenue (2018-2023)
2.3 Global Top Players by Obesity Treating Neuromodulation System Price (2018-2023)
2.4 Global Top Manufacturers Obesity Treating Neuromodulation System Manufacturing Base Distribution, Sales Area, Product Type
2.5 Obesity Treating Neuromodulation System Market Competitive Situation and Trends
2.5.1 Obesity Treating Neuromodulation System Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Obesity Treating Neuromodulation System Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Obesity Treating Neuromodulation System as of 2022)
2.7 Date of Key Manufacturers Enter into Obesity Treating Neuromodulation System Market
2.8 Key Manufacturers Obesity Treating Neuromodulation System Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Obesity Treating Neuromodulation System Status and Outlook by Region
3.1 Global Obesity Treating Neuromodulation System Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Obesity Treating Neuromodulation System Historic Market Size by Region
3.2.1 Global Obesity Treating Neuromodulation System Sales in Volume by Region (2018-2023)
3.2.2 Global Obesity Treating Neuromodulation System Sales in Value by Region (2018-2023)
3.2.3 Global Obesity Treating Neuromodulation System Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Obesity Treating Neuromodulation System Forecasted Market Size by Region
3.3.1 Global Obesity Treating Neuromodulation System Sales in Volume by Region (2024-2029)
3.3.2 Global Obesity Treating Neuromodulation System Sales in Value by Region (2024-2029)
3.3.3 Global Obesity Treating Neuromodulation System Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Obesity Treating Neuromodulation System by Application
4.1 Obesity Treating Neuromodulation System Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Ambulatory Surgical Centers
4.2 Global Obesity Treating Neuromodulation System Market Size by Application
4.2.1 Global Obesity Treating Neuromodulation System Market Size Overview by Application (2018-2029)
4.2.2 Global Obesity Treating Neuromodulation System Historic Market Size Review by Application (2018-2023)
4.2.3 Global Obesity Treating Neuromodulation System Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Obesity Treating Neuromodulation System Sales Breakdown by Application (2018-2023)
4.3.2 Europe Obesity Treating Neuromodulation System Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Obesity Treating Neuromodulation System Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Obesity Treating Neuromodulation System Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Obesity Treating Neuromodulation System Sales Breakdown by Application (2018-2023)
5 North America Obesity Treating Neuromodulation System by Country
5.1 North America Obesity Treating Neuromodulation System Historic Market Size by Country
5.1.1 North America Obesity Treating Neuromodulation System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Obesity Treating Neuromodulation System Sales in Volume by Country (2018-2023)
5.1.3 North America Obesity Treating Neuromodulation System Sales in Value by Country (2018-2023)
5.2 North America Obesity Treating Neuromodulation System Forecasted Market Size by Country
5.2.1 North America Obesity Treating Neuromodulation System Sales in Volume by Country (2024-2029)
5.2.2 North America Obesity Treating Neuromodulation System Sales in Value by Country (2024-2029)
6 Europe Obesity Treating Neuromodulation System by Country
6.1 Europe Obesity Treating Neuromodulation System Historic Market Size by Country
6.1.1 Europe Obesity Treating Neuromodulation System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Obesity Treating Neuromodulation System Sales in Volume by Country (2018-2023)
6.1.3 Europe Obesity Treating Neuromodulation System Sales in Value by Country (2018-2023)
6.2 Europe Obesity Treating Neuromodulation System Forecasted Market Size by Country
6.2.1 Europe Obesity Treating Neuromodulation System Sales in Volume by Country (2024-2029)
6.2.2 Europe Obesity Treating Neuromodulation System Sales in Value by Country (2024-2029)
7 Asia-Pacific Obesity Treating Neuromodulation System by Region
7.1 Asia-Pacific Obesity Treating Neuromodulation System Historic Market Size by Region
7.1.1 Asia-Pacific Obesity Treating Neuromodulation System Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Obesity Treating Neuromodulation System Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Obesity Treating Neuromodulation System Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Obesity Treating Neuromodulation System Forecasted Market Size by Region
7.2.1 Asia-Pacific Obesity Treating Neuromodulation System Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Obesity Treating Neuromodulation System Sales in Value by Region (2024-2029)
8 Latin America Obesity Treating Neuromodulation System by Country
8.1 Latin America Obesity Treating Neuromodulation System Historic Market Size by Country
8.1.1 Latin America Obesity Treating Neuromodulation System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Obesity Treating Neuromodulation System Sales in Volume by Country (2018-2023)
8.1.3 Latin America Obesity Treating Neuromodulation System Sales in Value by Country (2018-2023)
8.2 Latin America Obesity Treating Neuromodulation System Forecasted Market Size by Country
8.2.1 Latin America Obesity Treating Neuromodulation System Sales in Volume by Country (2024-2029)
8.2.2 Latin America Obesity Treating Neuromodulation System Sales in Value by Country (2024-2029)
9 Middle East and Africa Obesity Treating Neuromodulation System by Country
9.1 Middle East and Africa Obesity Treating Neuromodulation System Historic Market Size by Country
9.1.1 Middle East and Africa Obesity Treating Neuromodulation System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Obesity Treating Neuromodulation System Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Obesity Treating Neuromodulation System Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Obesity Treating Neuromodulation System Forecasted Market Size by Country
9.2.1 Middle East and Africa Obesity Treating Neuromodulation System Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Obesity Treating Neuromodulation System Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Medtronic
10.1.1 Medtronic Company Information
10.1.2 Medtronic Introduction and Business Overview
10.1.3 Medtronic Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Medtronic Obesity Treating Neuromodulation System Products Offered
10.1.5 Medtronic Recent Development
10.2 Cyberonics
10.2.1 Cyberonics Company Information
10.2.2 Cyberonics Introduction and Business Overview
10.2.3 Cyberonics Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Cyberonics Obesity Treating Neuromodulation System Products Offered
10.2.5 Cyberonics Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott Obesity Treating Neuromodulation System Products Offered
10.3.5 Abbott Recent Development
10.4 BioControl Medical
10.4.1 BioControl Medical Company Information
10.4.2 BioControl Medical Introduction and Business Overview
10.4.3 BioControl Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2018-2023)
10.4.4 BioControl Medical Obesity Treating Neuromodulation System Products Offered
10.4.5 BioControl Medical Recent Development
10.5 Leptos Medical
10.5.1 Leptos Medical Company Information
10.5.2 Leptos Medical Introduction and Business Overview
10.5.3 Leptos Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Leptos Medical Obesity Treating Neuromodulation System Products Offered
10.5.5 Leptos Medical Recent Development
10.6 ReShape Lifesciences
10.6.1 ReShape Lifesciences Company Information
10.6.2 ReShape Lifesciences Introduction and Business Overview
10.6.3 ReShape Lifesciences Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2018-2023)
10.6.4 ReShape Lifesciences Obesity Treating Neuromodulation System Products Offered
10.6.5 ReShape Lifesciences Recent Development
10.7 Nevro
10.7.1 Nevro Company Information
10.7.2 Nevro Introduction and Business Overview
10.7.3 Nevro Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Nevro Obesity Treating Neuromodulation System Products Offered
10.7.5 Nevro Recent Development
10.8 Nuvectra
10.8.1 Nuvectra Company Information
10.8.2 Nuvectra Introduction and Business Overview
10.8.3 Nuvectra Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Nuvectra Obesity Treating Neuromodulation System Products Offered
10.8.5 Nuvectra Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Obesity Treating Neuromodulation System Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Obesity Treating Neuromodulation System Industrial Chain Analysis
11.4 Obesity Treating Neuromodulation System Market Dynamics
11.4.1 Obesity Treating Neuromodulation System Industry Trends
11.4.2 Obesity Treating Neuromodulation System Market Drivers
11.4.3 Obesity Treating Neuromodulation System Market Challenges
11.4.4 Obesity Treating Neuromodulation System Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Obesity Treating Neuromodulation System Distributors
12.3 Obesity Treating Neuromodulation System Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
